Koers Almirall SA CBOE EUROPE EQUITIES
Aandelen
ES0157097017
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- EUR | - |
|
Omzet 2024 * | 975 mln. 1,04 mld. | Omzet 2025 * | 1,08 mld. 1,16 mld. | Marktkapitalisatie | 2,06 mld. 2,21 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 21 mln. 22,48 mln. | Nettowinst (verlies) 2025 * | 57 mln. 61,01 mln. | EV/omzet 2024 * | 2,14 x |
Nettoschuld 2024 * | 17,76 mln. 19,01 mln. | Nettoliquiditeiten 2025 * | 73,5 mln. 78,67 mln. | EV/omzet 2025 * | 1,84 x |
K/w-verhouding 2024 * |
93,9
x | K/w-verhouding 2025 * |
36,2
x | Werknemers | - |
Dividendrendement 2024 * |
1,59% | Dividendrendement 2025 * |
1,81% | Vrij verhandelbaar | 36,02% |
Recentste transcriptie over Almirall SA
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | 25-07-14 | |
Director of Finance/CFO | 54 | 11-11-19 | |
Karl Ziegelbauer
CTO | Chief Tech/Sci/R&D Officer | - | 07-07-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Seth J. Orlow
BRD | Director/Board Member | - | 01-01-16 |
Eva-Lotta Allan
BRD | Director/Board Member | 65 | 01-07-20 |
Director/Board Member | 65 | 01-01-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+41,96% | 630 mld. | |
-7,15% | 350 mld. | |
+18,77% | 328 mld. | |
+8,79% | 298 mld. | |
+18,02% | 246 mld. | |
+1,27% | 225 mld. | |
+11,95% | 218 mld. | |
+3,68% | 160 mld. | |
-4,38% | 156 mld. |